Caredx to report fourth quarter and full year 2023 financial results

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the fourth quarter and full year 2023 after market close on wednesday, february 28, 2024. company management will host a corresponding conference call beginning at 1:30 p.m. pacific time / 4:30.
CDNA Ratings Summary
CDNA Quant Ranking